Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-027219)

Filing Details

Accession Number:: 0001209191-15-027219
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-17 18:16:43
Reporting Period:: 2015-03-16

Filing Date:: 2015-03-17
Accepted Time:: 2015-03-17 18:16:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	244106690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601948	L Jeffrey Cleland	C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-16	80	$20.01	101,352	No	4	S	Direct
Common Stock	Disposition	2015-03-16	3	$20.03	101,349	No	4	S	Direct
Common Stock	Disposition	2015-03-17	738	$20.09	100,611	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 trading plan.
The shares were sold at prices ranging from $20.00 to $20.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.